ClassID:

21647

A61K2300/00 - page 84 - CPC Classification

Classification description:

Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups  - 

Recent Application in this class:
#24901
20050118694
2005-06-02

Method for producing probiotically derived compounds

#24902
20050118562
2005-06-02

Methods for minimizing spasticity in blood vessel grafts

#24903
20050118420
2005-06-02

Method for configuring air-core photonic-bandgap fibers free of surface modes

#24904
20050118312
2005-06-02

Physiologically synergistic mixtures of fruit components, methods of preparation thereof and methods of use thereof

#24905
20050118294
2005-06-02

Composition for weight reduction comprising water-soluble low-molecular weight chitosan and Hibiscus extract

#24906
20050118292
2005-06-02

Dioscorea extracts

#24907
20050118291
2005-06-02

Formulations and methods for treating breast cancer with Morinda citrifolia and methylsulfonymethane

#24908
20050118289
2005-06-02

Process for producing fat composition containing hydrophobic components of glycyrrhiza

#24909
20050118286
2005-06-02

Compositions and methods for treatment of nervous system disorders

#24910
20050118282
2005-06-02

Compositions and methods for inhibiting 5-alpha reductase

#24911
20050118279
2005-06-02

Mineral, nutritional, cosmetic, pharmaceutical, and agricultural compositions and methods for producing the same

#24912
20050118278
2005-06-02

Pharmaceutical or cosmetic composition, preventing or reducing itch and local reaction from stings of insects

#24913
20050118263
2005-06-02

Composition

#24914
20050118256
2005-06-02

Extended release alpha-2 agonist pharmaceutical dosage forms

#24915
20050118253
2005-06-02

Systemic delivery of serum stable plasmid lipid particles for cancer therapy

#24916
20050118242
2005-06-02

Androgen pharmaceutical composition and method for treating depression

#24917
20050118230
2005-06-02

Methods and compositions for regenerating connective tissue

#24918
20050118221
2005-06-02

Long acting parasiticidal composition containing a salicylanilide compound, a polymeric species and at least one other anti-parasitic compound

#24919
20050118215
2005-06-02

Inhibition of using botanical extracts

#24920
20050118202
2005-06-02

Solid compositions containing compounds unstable to oxygen and method for stabilization thereof

#24921
20050118194
2005-06-02

Oral vaccine, method for its preparation and use thereof

#24922
20050118187
2005-06-02

Combinations and methods for treating neoplasms

#24923
20050118180
2005-06-02

Inhibition of abnormal cell proliferation with camptothecin and combinations including the same

#24924
20050118173
2005-06-02

Compositions and methods to accelerate hematologic recovery

#24925
20050118162
2005-06-02

Treatment of micro-organism infection

#24926
20050118158
2005-06-02

Pharmacological vitreolysis

#24927
20050118156
2005-06-02

Storage-stable fibrin sealant

#24928
20050118153
2005-06-02

Antioxidant combination composition and use thereof

#24929
20050118118
2005-06-02

Lipid A-type compound and composition containing it

#24930
20050113574
2005-05-26

Methods and compositions comprising diamines as new anti-tubercular therapeutics

#24931
20050113452
2005-05-26

Composition and dosage form for sustained effect of levodopa

#24932
20050113441
2005-05-26

Composition that comprises ozonised oils and/or other natural and/or synthetic ozonised products, and use thereof in pharmaceutical, cosmetic, dietary or food supplement products, in the human and veterinary fields

#24933
20050113433
2005-05-26

Compositions of a phenyl acetic acid cyclooxygenase-2 selective inhibitor and a cholinergic agent for the treatment of reduced blood flow or trauma to the central nervous system

#24934
20050113427
2005-05-26

Use of peroxynirite scavengers or peroxynitrite formation inhibitors that do not diminish nitric oxide synthesis or activity to reverse or prevent premature vascular senescence

#24935
20050113421
2005-05-26

Thiazolidinone, oxazolidinone, and imidazolone derivatives for treating non-inflammatory gastrointestinal tract disorders

#24936
20050113409
2005-05-26

Method for the prevention or treatment of pain, inflammation and inflammation-related disorders with a Cox-2 selective inhibitor in combination with a nitric oxide-donating agent and compositions therewith

#24937
20050113384
2005-05-26

Combinations of (a) an atp-competitive inhibitor of c-acl kinase activity with (b) two or more other antineoplastic agents

#24938
20050113381
2005-05-26

Pyridazinone aldose reductase inhibitors

#24939
20050113376
2005-05-26

Compositions of a cyclooxygenase-2 selective inhibitor, a xanthine compound and an alcohol for the treatment of ischemic mediated central nervous system disorders or injury

#24940
20050113371
2005-05-26

Antifungal agent for topical use

#24941
20050113367
2005-05-26

Pharmaceutical composition

#24942
20050113365
2005-05-26

Method and medicine for treating gastrointestinal disorder including irritable bowel syndrome

#24943
20050113362
2005-05-26

Substituted phenypropionic acid derivatives as agonists to human peroxisome proliferator-activated receptor α(PPAR)

#24944
20050113354
2005-05-26

Bioavailable prodrugs of androgenic steroids and related method

#24945
20050113353
2005-05-26

Pharmaceutical composition and method for treating hypogonadism

#24946
20050113334
2005-05-26

Composition and method

#24947
20050113333
2005-05-26

Compositions for ameliorating fecal properties

#24948
20050113332
2005-05-26

Compositions and methods for treating an arthritic condition

#24949
20050113331
2005-05-26

Compositions and methods for use of antiviral drugs in the treatment of retroviral diseases resistant to nucleoside reverse transcriptase inhibitors

#24950
20050113321
2005-05-26

DAPD combination therapy with inosine monophosphate dehydrogenase inhibitor

#24951
20050113318
2005-05-26

Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a beta-agonist bronchodilator for treatment of asthma or chronic obstructive pulmonary disease

#24952
20050113314
2005-05-26

Cicletanine in combination with oral antidiabetic and/or blood lipid-lowering agents as a combination therapy for diabetes and metabolic syndrome

#24953
20050113310
2005-05-26

Use of inhibitors of enzymes having activities of amino peptidase N and/or dipeptidyl peptidase IV and of pharmaceutical preparations thereof for a therapy and prevention of chronical neurodegenerative diseases

#24954
20050113307
2005-05-26

Methods of treating cancer and the pain associated therewith using endothelin antagonists

#24955
20050113306
2005-05-26

Methods of treating cancer and the pain associated therewith using endothelin antagonists

#24956
20050113305
2005-05-26

Compounds and methods for modulating cell-adhesion mediated drug resistance

#24957
20050113301
2005-05-26

Treatment of subnormal bone mineral density

#24958
20050113291
2005-05-26

Use of SARP-1 for the treatment and/or prevention of scleroderma

#24959
20050113287
2005-05-26

Composition to enhance joint function and repair

#24960
20050112219
2005-05-26

Vapor fraction from seeds of (L.) Merr. and composition thereof

#24961
20050112213
2005-05-26

Saccharide compositions and method of use

#24962
20050112212
2005-05-26

Herbal formulation

#24963
20050112210
2005-05-26

Eye nutritional supplement

#24964
20050112208
2005-05-26

Composition for the treatment of burns, sunburns, abrasions, ulcers and cutaneous irritation

#24965
20050112200
2005-05-26

EDTA containing compositions and uses thereof

#24966
20050112199
2005-05-26

Therapeutic regimens for administering drug combinations

#24967
20050112195
2005-05-26

Drug coating providing high drug loading

#24968
20050112187
2005-05-26

Combination product intended for carrying out a cytotoxic treatment, in particular an antitumour treatment, in a mammal

#24969
20050112181
2005-05-26

Pharmaceutical composition and method for treating hypogonadism

#24970
20050112178
2005-05-26

Nutritional dietary kit for use in preparing an individual for gastrointestinal procedure

#24971
20050112176
2005-05-26

Nutritional supplement composition and method

#24972
20050112153
2005-05-26

Dermatological composition

#24973
20050112150
2005-05-26

Polypeptide expressed in the horny layer of the epidermis and its use

#24974
20050112130
2005-05-26

Enhanced B cell cytotoxicity of CDIM binding antibody

#24975
20050112128
2005-05-26

Inhibition of protein kinase c-mu (PKD) as a treatment for cardiac hypertrophy and heart failure

#24976
20050112123
2005-05-26

Methods of treating proteinuria

#24977
20050112122
2005-05-26

Generation of hematopoietic chimerism and induction of central tolerance

#24978
20050112113
2005-05-26

Presbyopia treatment by lens alteration

#24979
20050112112
2005-05-26

Microorganism for treatment or prevention of corpulence and diabetes mellitus, and pharmaceutical composition containing the same

#24980
20050112111
2005-05-26

Stabilized dihydrolipoic acid and method of producing same

#24981
20050112105
2005-05-26

Compositions and treatments for myelosuppression by ex vivo activated immune cells

#24982
20050112097
2005-05-26

Method for the treatment of cancer

#24983
20050112093
2005-05-26

Combination therapy for HCV infection

#24984
20050112091
2005-05-26

Local intraosseous administration of bone forming agents and anti-resorptive agents, and devices therefor

#24985
20050112090
2005-05-26

Death domain containing receptor 4 antibodies and methods

#24986
20050112078
2005-05-26

Plant-derived protein extract compositions and methods

#24987
20050112071
2005-05-26

Hypoestoxides, derivatives, agonists and crude extracts thereof for use in cosmetic compositions

#24988
20050112069
2005-05-26

Pharmaceutical composition of a pde4 or pde 3/4 inhibitor and histamine receptor antagonist

#24989
20050112066
2005-05-26

Complexes of cyclic polyaza chelators with cations of alkaline earth metals for enhanced biological activity

#24990
20050112061
2005-05-26

Use of a VEGF antagonist in combination with radiation therapy

#24991
20050112059
2005-05-26

Enhancement of radiotherapy by an exogenous cardiac glycoside

#24992
20050112021
2005-05-26

Reduction of Contaminants In Blood and Blood Products Using Photosensitizers and Peak Wavelengths of Light

#24993
20050109981
2005-05-26

Decontamination formulations for disinfection and sterilization

#24994
20050107474
2005-05-19

Pharmaceutical compositions for the treatment of infections of the respiratory system by pathogenic agents

#24995
20050107470
2005-05-19

Combined use of l-carnitine, acetyl l-carnitine and propionyl l-carnitine for the treatment of oligoasthenoteratospermia

#24996
20050107465
2005-05-19

Composition for treating inflammatory bowel disease

#24997
20050107463
2005-05-19

Prostamides for the treatment of glaucoma and related diseases

#24998
20050107461
2005-05-19

Drug combination therapy

#24999
20050107452
2005-05-19

Black soybean polysaccharides

#25000
20050107450
2005-05-19

Dosing regimen for ppar-gamma activators

#25001
20050107446
2005-05-19

Pharmaceutical compositions of amlodipine and atorvastatin

#25002
20050107439
2005-05-19

Composition and method for treating emesis

#25003
20050107425
2005-05-19

Treatment of attention defecit hyperactivity disorder

#25004
20050107421
2005-05-19

Imidazonaphthyridines

#25005
20050107420
2005-05-19

Combination of a PDE4 inhibitor and tiotropium or derivative thereof for treating obstructive airways and other inflammatory diseases

#25006
20050107417
2005-05-19

Medicaments for inhalation comprising a novel anticholinergic and a betamimetic

#25007
20050107416
2005-05-19

17-hydroxy-4-aza-androstan-3-ones as androgen receptor modulators

#25008
20050107387
2005-05-19

Compositions of a cyclooxygenase-2 selective inhibitor and a peroxisome proliferator activated receptor agonist for the treatment of ischemic mediated central nervous system disorders

#25009
20050107380
2005-05-19

Brain, spinal and nerve injury treatment

#25010
20050107356
2005-05-19

Combination of a CB1 receptor antagonist and of a product which activates dopaminergic neurotransmission in the brain, the pharmaceutical compositions comprising them and their use in the treatment of parkinson's disease

#25011
20050107354
2005-05-19

Agents for the prevention or treatment of renal diseases

#25012
20050107353
2005-05-19

Methods of treating lower urinary tract disorders using losigamone

#25013
20050107351
2005-05-19

Graduated estrogen contraceptive

#25014
20050107350
2005-05-19

Method for the treatment or prevention of bone disorders with a cyclooxygenase-2 inhibitor alone and in combination with a bone disorder treatment agent and compositions therewith

#25015
20050107346
2005-05-19

N-acetylcolchinol-o-phosphate combination therapies with vascular damaging activity

#25016
20050107338
2005-05-19

Nutritional supplement enhancing mitochondrial function

#25017
20050107330
2005-05-19

Pharmaceutical composition for the treatment of rhinitis

#25018
20050107323
2005-05-19

Cardiac arrhythmia treatment methods

#25019
20050107320
2005-05-19

Methods and compositions for use in interventional pharmacogenomics

#25020
20050107306
2005-05-19

Treatment of respiratory disease associated with matrix metalloproteases by inhalation of synthetic matrix metalloprotease inhibitors

#25021
20050107302
2005-05-19

Wound healing composition and method for use thereof

#25022
20050107287
2005-05-19

Treatment of cancers by inhalation of stable platinum-containing formulations

#25023
20050106553
2005-05-19

Storage of materials

#25024
20050106276
2005-05-19

Pharmaceutical composition made from Chinese traditional medecine and method of producing thereof

#25025
20050106273
2005-05-19

Appetite suppressant

#25026
20050106272
2005-05-19

Co-beadlet of dha and rosemary and methods of use

#25027
20050106271
2005-05-19

Eye drops

#25028
20050106269
2005-05-19

Increasing cerebral bioavailability of drugs

#25029
20050106263
2005-05-19

Green tea, multivitamin, mineral and herb based hair and male facial skin formulas

#25030
20050106262
2005-05-19

Pharmaceutical composition comprising arsenite for the treatment of malignancy

#25031
20050106261
2005-05-19

Method for the accelerated in vivo removal of ethanol

#25032
20050106258
2005-05-19

Pharmacology and manufacturing method of Bombyx moriL related bioproduct

#25033
20050106249
2005-05-19

Once-a-day, oral, controlled-release, oxycodone dosage forms

#25034
20050106246
2005-05-19

Controlled release arginine α-ketoglutarate

#25035
20050106244
2005-05-19

Ibuprofen and narcotic analgesic compositions

#25036
20050106234
2005-05-19

Calcium formate for use as a dietary supplement

#25037
20050106218
2005-05-19

Compositions and methods for treatment of body weight conditions

#25038
20050106215
2005-05-19

Food or pet food composition containing plant extract for bone health

#25039
20050106202
2005-05-19

Endoparasiticidal gel composition

#25040
20050106191
2005-05-19

Antiseptic bactericides and cosmetics, drugs and foods containing the antiseptic bactericides

#25041
20050106183
2005-05-19

Method of treating pain

#25042
20050106165
2005-05-19

Additive for livestock feed

#25043
20050106151
2005-05-19

Inhibitors of serine protease activity and their use in methods and compositions for treatment of bacterial infections

#25044
20050106148
2005-05-19

Method of treating anemia by administering IL-1ra

#25045
20050106135
2005-05-19

Compositions, kits and treating methods for alteration cell-cell adhesion, transport, or permeation properties of tissues

#25046
20050106132
2005-05-19

Growth promoting prebiotic for lactobacillus dietary supplements

#25047
20050106131
2005-05-19

Photoprotective orally administrable composition for skin

#25048
20050106128
2005-05-19

Novel methods of treatment and deliver modes

#25049
20050106121
2005-05-19

Antimicrobial composites, films, labelstocks, and labels

#25050
20050106113
2005-05-19

Composition for the treatment of dental and periodontal diseases

#25051
20050101691
2005-05-12

Anti-microbial tool grip

#25052
20050101674
2005-05-12

PPMP as a ceramide catabolism inhibitor for cancer treatment

#25053
20050101658
2005-05-12

Use of inhibitors of the renin-angiotensin system in the prevention of cardiovascular events

#25054
20050101657
2005-05-12

Androgen receptor antagonists

#25055
20050101655
2005-05-12

Migraine treatments including isovaleramide compounds and serotonin agonists

#25056
20050101653
2005-05-12

Combination therapy for the treatment of migraine

#25057
20050101642
2005-05-12

Chemical complex comprising a pyridine carboxy derivative and an H2 histamine receptor antagonist

#25058
20050101640
2005-05-12

Lisinopril/lercanidipine combination therapy

#25059
20050101638
2005-05-12

Combination of organic compounds

#25060
20050101632
2005-05-12

Method for the treatment of inflammation

#25061
20050101629
2005-05-12

Compositions of a chromene cyclooxygenase-2 selective inhibitor and a cholinergic agent for the treatment of reduced blood flow or trauma to the central nervous system

#25062
20050101618
2005-05-12

Selective erbB2 inhibitor/anti-erbB antibody combinations in the treatment of cancer

#25063
20050101607
2005-05-12

Pharmaceutical composition containing a beta-3-adrenoceptor agonist and an alpha antagonist and/or a 5-alpha reductase inhibitor

#25064
20050101605
2005-05-12

Oral liquid formulations of methotrexate

#25065
20050101597
2005-05-12

Compositions of a cyclooxygenase-2 selective inhibitior and a non-NMDA glutamate modulator for the treatment of central nervous system damage

#25066
20050101594
2005-05-12

Compositions useful as inhibitors of protein kinases

#25067
20050101580
2005-05-12

Topical skin care composition

#25068
20050101579
2005-05-12

Endometriosis treatment protocol

#25069
20050101576
2005-05-12

Methods of using vitamin D compounds in the treatment of myelodysplastic syndromes

#25070
20050101571
2005-05-12

Methods of treating cancer using a combination of drugs

#25071
20050101565
2005-05-12

Pharmaceutical compositions and methods for treating, preventing, and managing cholesterol, dyslipidemia, and related disorders

#25072
20050101563
2005-05-12

Method and compositions for the treatment and prevention of pain and inflammation

#25073
20050101561
2005-05-12

HDL-boosting combination therapy complexes

#25074
20050101545
2005-05-12

Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anticholinergic bronchodilator for treatment of asthma or chronic obstructive pulmonary disease

#25075
20050101544
2005-05-12

Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a leukotriene receptor antagonist for treatment of asthma or chronic obstructive pulmonary disease

#25076
20050101542
2005-05-12

Combination therapy for controlling appetites

#25077
20050101537
2005-05-12

Use of exendins and agonists thereof for lowering plasma lipid

#25078
20050101535
2005-05-12

Use of a synthetic alpha-melanocyte stimulating hormone agonist to decrease steroid induced weight gain

#25079
20050101522
2005-05-12

Preparation for the prophylaxis of restenosis

#25080
20050100891
2005-05-12

Gene expression profile for KSHV infection and methods for treating same

#25081
20050100643
2005-05-12

Microbiological control in poultry processing

#25082
20050100637
2005-05-12

Carbohydrate and electrolyte replacement composition

#25083
20050100622
2005-05-12

Dietary food supplement containing natural cyclooxygenase inhibitors and methods for inhibiting pain and inflammation

#25084
20050100621
2005-05-12

Dermatological compositions

#25085
20050100620
2005-05-12

Compositions of oak bark extract, related synthetic compositions, and method of using same

#25086
20050100619
2005-05-12

Cholesterol lowering supplement

#25087
20050100618
2005-05-12

Method of using a compound of menthol and L-arginine as a preparation for the topical delivery of Icariin, a herbal product produced from the Epimedium genus of the Berberidaceal family of plants, for the treatment of sexual dysfunction

#25088
20050100616
2005-05-12

Preventive or therapeutic agent for pollen allergy, allergic rhinitis, atopic dermatitis, asthma or urticaria, or health food for prevention or improvement or reduction of symptoms thereof

#25089
20050100615
2005-05-12

Process for controlling water and electrolyte balance and acid-base equilibrium in human body

#25090
20050100614
2005-05-12

Method and composition for preventing or reducing the symptoms of insulin resistance syndrome

#25091
20050100612
2005-05-12

Virucidal activities of cetylpyridinium chloride

#25092
20050100611
2005-05-12

Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds

#25093
20050100610
2005-05-12

Use of bioactive fraction from cow urine distillate (‘’) as a bio-enhancer of anti-infective, anti-cancer agents and nutrients

#25094
20050100601
2005-05-12

Virucidal activities of cetylpyridinium chloride

#25095
20050100594
2005-05-12

Pharmaceutical formulation containing muscle relaxant and COX-II inhibitor

#25096
20050100592
2005-05-12

Methods for treatment of human skin damaged by laser treatment or chemical peelings and compositions useful in such methods

#25097
20050100587
2005-05-12

Topical analgesic and methods of use

#25098
20050100567
2005-05-12

Liquid concentrate for the preservation of cosmetic and pharmaceutical products

#25099
20050100542
2005-05-12

Cytotoxicity mediation of cells evidencing surface expression of CD44

#25100
20050100538
2005-05-12

Intradiscal injection of anti-oxidants

#25101
20050100537
2005-05-12

Methods and kits for reducing cellular damage, inhibiting free radical production, and scavenging free radicals in mammals

#25102
20050100535
2005-05-12

Methods for the dietary management of irritable bowel syndrome and carbohydrate malabsorption

#25103
20050100529
2005-05-12

Methods of using and compositions comprising immunomodulatory compounds for the treatment and management of asbestos-related diseases and disorders

#25104
20050100526
2005-05-12

Antibiotic polymers

#25105
20050100524
2005-05-12

Skin formulation

#25106
20050100513
2005-05-12

Homeopathic method and system for treating nicotine addiction

#25107
20050096391
2005-05-05

Compositions comprising fenofibrate and rosuvastatin

#25108
20050096390
2005-05-05

Compositions comprising fenofibrate and pravastatin

#25109
20050096364
2005-05-05

Iminothiazolidinones as inhibitors of HCV replication

#25110
20050096344
2005-05-05

Tyrosine kinase inhibitors

#25111
20050096339
2005-05-05

Morphogen-induced modulation of inflammatory response

#25112
20050096314
2005-05-05

Treatment of cancers with methylol-containing compounds and at least one electrolyte

#25113
20050096311
2005-05-05

Compositions and methods for treatment of nervous system disorders

#25114
20050096307
2005-05-05

Combinations of lipid modulating agents and substituted azetidinones and treatments for vascular conditions

#25115
20050096305
2005-05-05

Augmentation of atypical antipsychotic agent pharmacotherapy with chromium supplementation

#25116
20050096304
2005-05-05

Method of treating cancer using dithiocarbamate derivatives

#25117
20050096303
2005-05-05

Cardiovascular protection using anti-aldosteronic progestins

#25118
20050096286
2005-05-05

Treatment of hypercholesterolemia or diabetes associated angiogenic defects

#25119
20050096274
2005-05-05

Bone morphogenetic protein and fibroblast growth factor compositions and methods for the induction of cardiogenesis

#25120
20050096262
2005-05-05

Helicobacter pylori adhesion inhibitor

#25121
20050096257
2005-05-05

Combination therapy for the treatment of ocular neovascular disorders

#25122
20050096256
2005-05-05

Compositions for manipulating the lifespan and stress response of cells and organisms

#25123
20050095705
2005-05-05

Method for production of oncolytic adenoviruses

#25124
20050095306
2005-05-05

Method of using geranium oil and sophora root extracts as a supporting composition in cancer treatments

#25125
20050095304
2005-05-05

Composition and method for smoke detoxification

#25126
20050095301
2005-05-05

Stable beadlets of lipophilic nutrients

#25127
20050095300
2005-05-05

Controlled release analgesic suspensions

#25128
20050095288
2005-05-05

Decongestant and expectorant tablets

#25129
20050095277
2005-05-05

Neuropathy cream

#25130
20050095270
2005-05-05

Drug delivery to the inner ear and methods of using same

#25131
20050095262
2005-05-05

Multivitamin syrup for children or young adults

#25132
20050095250
2005-05-05

Therapeutical combination against cancer

#25133
20050095244
2005-05-05

Fully human antibodies against human 4-1BB

#25134
20050095243
2005-05-05

Combination therapy for B cell disorders

#25135
20050095238
2005-05-05

Method of administering an antibody

#25136
20050095234
2005-05-05

Method of inducing or enhancing chondrogenesis with extracellular matrix containing GDF-5

#25137
20050095232
2005-05-05

Vaginal care composition

#25138
20050095231
2005-05-05

Modified adenovirus containing a fiber replacement protein

#25139
20050095224
2005-05-05

Compositions and method for treating hepatitis virus infection

#25140
20050095205
2005-05-05

Combination of loteprednol etabonate and tobramycin for topical ophthalmic use

#25141
20050092969
2005-05-05

Method of stabilizing compound having quinone skeleton and stabilized composition

#25142
20050090693
2005-04-28

Substituted bicylo[3.3.1]nonan-2,4,9-triones as pharmaceutical active ingredients

#25143
20050090553
2005-04-28

Compositions and method for treatment of chronic inflammatory diseases

#25144
20050090551
2005-04-28

Therapeutic use of methionine for the treatment or prevention of mucositis

#25145
20050090547
2005-04-28

Combinations of retigabine and sodium channel inhibitors or sodium channel-influencing active compounds for treating pains

#25146
20050090545
2005-04-28

Nitric oxide topical technology

#25147
20050090543
2005-04-28

Method for the preparation of tetrahydrobenzothiepines

#25148
20050090538
2005-04-28

Analgesic and anti-inflammatory compositions containing Cox-2-inhibitors

#25149
20050090537
2005-04-28

Pharmaceutical composition based on a polymorphic form I of idazoxan

#25150
20050090527
2005-04-28

Combination of H1, H3 and H4 receptor antagonists for treatment of allergic and non-allergic pulmonary inflammation, congestion and allergic rhinitis

#25151
20050090520
2005-04-28

Treatment of disease or injury of the nervous system with FTY720

#25152
20050090518
2005-04-28

Method for treating parkinson's disease using apomorphine and apomorphine prodrugs

#25153
20050090517
2005-04-28

Pharmaceutical combinations of cox-2 inhibitors and opiates

#25154
20050090511
2005-04-28

Method of preventing infectious diseases

#25155
20050090500
2005-04-28

Treating abnormal cell growth with a stable polymorph of N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine hydrochloride

#25156
20050090488
2005-04-28

Drug combination for the treatment of depression and related disorders comprising mirtazapine

#25157
20050090482
2005-04-28

Potentiators of antibacterial activity

#25158
20050090480
2005-04-28

Use of selected amino acid-zinc complexes as anti-malarials

#25159
20050090475
2005-04-28

Extended triphasic contraceptive regimens

#25160
20050090474
2005-04-28

Methods and compositions for enhancing and inhibiting fertilization

#25161
20050090454
2005-04-28

Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an antihistamine for treatment of asthma or chronic obstructive pulmonary disease

#25162
20050090451
2005-04-28

Treatment of cancer with glutamine

#25163
20050090444
2005-04-28

Methods and apparatus for creating particle derivatives of HDL with reduced lipid content

#25164
20050090433
2005-04-28

Dalbavancin compositions for treatment of bacterial infections

#25165
20050090424
2005-04-28

Use of melagatran for the manufacture of a medicament for the treatment of Type 1 diabetes mellitus

#25166
20050089929
2005-04-28

Antibodies for inhibiting blood coagulation and methods of use thereof

#25167
20050089592
2005-04-28

Nut skin products

#25168
20050089588
2005-04-28

Dietary supplements containing natural ingredients

#25169
20050089587
2005-04-28

Procedure for the preparation of microbiological associations intended to strengthen the medicinal herb's therapeutic qualities

#25170
20050089585
2005-04-28

Herbal composition for treating CD33+ acute and chronic myeloid leukemia and a method thereof

#25171
20050089584
2005-04-28

Methods and compositions for oral delivery of Areca and mate' or theobromine

#25172
20050089583
2005-04-28

Herbal composition for the treatment of gastric ulcer

#25173
20050089575
2005-04-28

Bilayer pharmaceutical tablet comprising telmisartan and a diuretic and preparation thereof

#25174
20050089570
2005-04-28

Oros push-stick for controlled delivery of active agents

#25175
20050089559
2005-04-28

Combinations of potassium channel openers and sodium channel inhibitors or sodium channel-influencing active compounds for treating pains

#25176
20050089558
2005-04-28

Compositions and methods for the co-formulation and administration of tramadol and propoxyphene

#25177
20050089555
2005-04-28

Medicinal targeted local lipolysis

#25178
20050089546
2005-04-28

Compositions and methods comprising complex carbohydrate and alpha-lactalbumin

#25179
20050089539
2005-04-28

Antimicrobial compositions and methods

#25180
20050089523
2005-04-28

Methods for imaging tumor vasculature using conjugates that bind to aminophospholipids

#25181
20050089509
2005-04-28

Treatment of Francisella infection with an IFN-gamma inducer and a chemotherapeutic agent

#25182
20050089501
2005-04-28

Composition based on natural substances useful in the maintenance of the correct hydration of the skin

#25183
20050089499
2005-04-28

Active substances for use in cosmetic and/or pharmaceutical products, obtainable from the fermentation of plant components and/or plant extracts

#25184
20050089485
2005-04-28

Sulfacetamide formulations for treatment of rosacea

#25185
20050089477
2005-04-28

Medicaments

#25186
20050089473
2005-04-28

Potassium channel mediated delivery of agents through the blood-brain barrier

#25187
20050087452
2005-04-28

Antioxidant sensor, methods and compositions

#25188
20050085652
2005-04-21

Preparation and purification of synthetic capsaicin

#25189
20050085551
2005-04-21

Bupropion to treat viral diseases

#25190
20050085548
2005-04-21

Method and formulation for treating vascular disease

#25191
20050085542
2005-04-21

Use of L-carnitine and its alkanoyl derivatives as osmotic agents in solutions for medical use

#25192
20050085528
2005-04-21

Parmaceutical

#25193
20050085498
2005-04-21

Oral formulation of lipid soluble thiamine, lipoic acid, creatine derivative, and L-arginine alpha-ketoglutarate

#25194
20050085489
2005-04-21

Pharmaceutical composition comprising a glitazone and a 4-oxobutanoic acid, and the use thereof for treating diabetes

#25195
20050085479
2005-04-21

Mediated central nervous system compositions of a cyclooxygenase-2 selective inhibitor and a corticotropin releasing factor antagonist for the treatment of ischemic disorders or injury

#25196
20050085478
2005-04-21

Compositions of a cyclooxygenase-2 selective inhibitor and a low-molecular-weight heparin for the treatment of central nervous system damage

#25197
20050085477
2005-04-21

Compositions of a cyclooxygenase-2 selective inhibitor and a serotonin-modulating agent for the treatment of neoplasia

#25198
20050085450
2005-04-21

Oral antidepressant formulation

#25199
20050085448
2005-04-21

Production of pure stereoisomers of tricyclo[5.2.1.0]-dec-9-yl-xanthogenate and medicaments therefrom

#25200
20050085446
2005-04-21

Fluoroquinolone formulations and methods of making and using the same